ISCO · International Stem Cell CORP · Executive Compensation
$0.18
-0.08 (-31.31%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.44M
Shares
8.00M
Volume · Oct 21
242.16K
Avg daily vol (3M)
35.55K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Russell Kern | — | $370,000 |
| Andrey Semechkin | — | $88,544 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Russell Kern | — | $260,000 |
| Andrey Semechkin | — | $66,480 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Russell Kern | — | $377,237 |
| Andrey Semechkin | — | $112,865 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Russell Kern | — | $439,943 |
| Andrey Semechkin | — | $396,143 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Sophia Garnette | — | $257,797 |
| Andrey Semechkin | — | $125,893 |
| Russell Kern | — | $125,893 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Sophia Garnette | — | $169,961 |
| Andrey Semechkin | — | $53,968 |
| Russell Kern | — | $53,968 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Sophia Garnette | — | $285,633 |
| Andrey Semechkin | — | $201,208 |
| Russell Kern | — | $166,320 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Sophia Garnette | — | $457,215 |
| Andrey Semechkin | — | $420,457 |
| Russell Kern | — | $325,621 |
Leadership
- Andrey Semechkin CEO, Board Member
- Russell Kern CFO, Board Member
- Donald A. Wright Board Member
- Paul V. Maier Board Member